US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about NASDAQ:COYA

Recent news which mentions NASDAQ:COYA

COYA Stock Earnings: Coya Therapeutics Misses EPS, Misses Revenue for Q2 2024
Tickers COYA
Tags NASDAQ:COYA COYA Market News
From InvestorPlace
COYA Stock Earnings: Coya Therapeutics Misses EPS for Q1 2024
Tickers COYA
Tags NASDAQ:COYA Market News Earnings Reports
From InvestorPlace
COYA Stock Earnings: Coya Therapeutics Reported Results for Q4 2023
Tickers COYA
Tags COYA Market News NASDAQ:COYA
From InvestorPlace
Headline
Tags NASDAQ:COYA
From News Direct
There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Study
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is a Major Moment For Drug Development
Tickers BLUE COYA GOVX LLY
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics’ COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Houston-Based Coya Therapeutics Partners With Multi-Billion Dollar Global Drug Company Dr. Reddy’s Laboratories To License and Commercialize COYA 302
Tickers COYA RDY
Tags NASDAQ:COYA
From News Direct
This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine’s Next Frontier?
Tickers COYA LLY NVS
Tags NASDAQ:COYA
From News Direct
Houston-Based Coya Therapeutics To Present Results From ALS Clinical Study Data For Its Investigational Biologic Combination at the 2023 MDA Clinical & Scientific Conference in Dallas
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics’ Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Tickers COYA XGN
Tags NASDAQ:COYA
From News Direct